--- domain: spirituality tags: [harmonism, wheel-of-harmony, wheel-of-presence, spirituality, entheogens, field-map] content_layer: bridge doctrinal_status: clouded breadth: full depth: introductory craft: muddy published: "2026-05-17" updated: "2026-09-02" canonical_url: https://harmonism.io/wheel-of-harmony/presence/entheogens/entheogen-field-map site: Harmonia — harmonism.io --- # Entheogen Field Map — Voices, Organizations & Landscape > **Harmonism Location:** Wheel of Presence → Entheogen Pillar > **Scope:** A map of the contemporary psychedelic/entheogen/sacred-plant field — its voices, organizations, and lineages. --- ## Foundational Intellectual Lineage - **Aldous Huxley** — *The Doors of Perception*; perennialist-phenomenological framing of the psychedelic experience - **R. Gordon Wasson** — Ethnomycology; the Mazatec velada; brought psilocybin mushrooms to Western awareness - **Albert Hofmann** — LSD synthesis (1938/1943); later philosophical reflection on entheogens - **Stanislav Grof** — Transpersonal cartography; holotropic breathwork; perinatal matrices; the elder architect of consciousness mapping through psychedelics - **Terence McKenna** — Speculative-visionary framing (stoned ape hypothesis, timewave); influential but epistemically uneven - **Ralph Metzner** — Harvard lineage carried into ecological and alchemical directions - **Ram Dass (Richard Alpert)** — Harvard lineage carried into contemplative practice (Be Here Now) - **Huston Smith** — Perennialist philosophical lens; *Cleansing the Doors of Perception* - **Alexander Shulgin** — Rediscovery of MDMA; *PiHKAL* and *TiHKAL*; systematic exploration of phenethylamines and tryptamines - **Claudio Naranjo** — Early integration of iboga and ayahuasca into psychotherapy; bridged indigenous practice and clinical work --- ## Living Voices — Clinical & Scientific Axis ### Tier 1: Field-Defining - **Robin Carhart-Harris** (UCSF, formerly Imperial College) — Leading neuroscientific theorist; entropic brain hypothesis; REBUS model (Relaxed Beliefs Under Psychedelics). Scientific correlate of mystical opening. - **Matthew Johnson** (Johns Hopkins) — Psilocybin for addiction and depression; bridges clinical and philosophical - **Roland Griffiths** (Johns Hopkins, d. 2023) — Among the most important figures in legitimizing psilocybin within mainstream science. Legacy continues through the Hopkins center. - **Rachel Yehuda** (Mount Sinai) — Trauma biology credibility applied to MDMA research - **David Nutt** (Imperial College) — Drug policy reform; neuropsychopharmacology - **Rick Doblin** (MAPS founder) — 40+ years building infrastructure for clinical legitimacy; the most important policy figure in the field's modern history ### Tier 2: Major Contributors - **Gül Dölen** — Neuroplasticity research; psychedelics reopening critical periods of social learning (one of the most theoretically significant neuroscience findings in recent years) - **Nolan Williams** (Stanford) — Accelerated therapeutic protocols - **Michael Bogenschutz** — Psilocybin for alcohol use disorder - **Alan K. Davis** — Clinical trials, 5-MeO-DMT research - **Stephen Ross** (NYU) — Psilocybin for end-of-life anxiety - **Ben Sessa** (UK) — MDMA-assisted therapy - **Joshua Siegel** (Hopkins) — Psilocybin and brain connectivity desynchronization - **Ben Kelmendi** — OCD and psychedelics - **Amy Lehrner** — VA psychedelic-assisted therapy for veterans ### Key Popularizers & Bridge Figures - **Michael Pollan** — *How to Change Your Mind*; single biggest mainstream popularization event of the last decade - **James Fadiman** — *The Psychedelic Explorer's Guide*; microdosing protocol framework - **Paul Stamets** — Mycologist; psilocybin advocate; commercial operations (Fungi Perfecti); most publicly visible mushroom voice - **Gabor Maté** — Trauma-informed clinical framing applied to ayahuasca work --- ## Living Voices — Philosophical & Transpersonal Axis - **Alberto Villoldo** (Four Winds Society) — Embodied shamanic practice mapped to energy centers; Q'ero and Amazonian lineages. *Already integrated into Harmonism via eight-chakra system. A primary cartography.* - **Dennis McKenna** — Ethnobotany; more empirically grounded than Terence - **Jeremy Narby** — *The Cosmic Serpent*; DNA-vision hypothesis connecting molecular biology with ayahuasca phenomenology - **Chris Bache** — *LSD and the Mind of the Universe*; most serious modern attempt at transpersonal cartography through sustained high-dose sessions - **Amanda Feilding** (Beckley Foundation) — Bridges philosophical and scientific; instrumental in enabling Imperial College research; consciousness-science champion - **Benny Shanon** — *The Antipodes of the Mind*; most rigorous phenomenological analysis of ayahuasca cognition from philosophy-of-mind standpoint - **Graham Hancock** — Popularizer of entheogenic origins-of-consciousness thesis; broad reach but less rigorous --- ## Indigenous & Sacred-Traditional Lineages ### Ayahuasca Traditions - **Shipibo people** (Peruvian Amazon) — Primary lineage most Westerners encounter; time-honored plant-spirit shamanism; icaros (healing songs); pattern cosmology representing the oneness of creation - **Santo Daime / União do Vegetal** — Syncretic Brazilian ayahuasca churches; formalized sacramental container - **Mestizo curanderismo** — Mixed-lineage healers throughout Upper Amazon (Peru, Colombia, Ecuador) ### Psilocybin Mushrooms - **Mazatec tradition** — María Sabina's lineage (Oaxaca, Mexico); the original indigenous container for Western psilocybin encounter ### Peyote / Mescaline - **Native American Church** — Peyote sacrament; legal religious exemption in the US - **Wixárika / Huichol** (Mexico) — Peyote pilgrimage tradition; among the oldest continuous ceremonial uses ### San Pedro / Huachuma - **Q'ero people** (Peru) — Primary carriers of Andean mesa tradition; San Pedro ceremony; direct descendants of Inca lineage. *Villoldo's primary indigenous source.* ### Iboga - **Bwiti tradition** (Gabon) — Iboga as sacrament; initiatory and healing contexts; 24+ hour journey; considered a "reset" for mind, body, spirit. Ibogaine blocks the cardiac hERG channel and prolongs the QT interval to the point of ventricular arrhythmia; the documented deaths cluster twelve to seventy-six hours after the dose, inside and just beyond the journey this line describes, from the long-lived metabolite noribogaine. It is not a practice a reader undertakes; outside continuous cardiac monitoring it is the most lethal agent on this map ### Western Bridge Figures (Serious Lineage Work) - Alberto Villoldo (Q'ero and Amazonian) - Rak Razam (*Aya: Awakenings*) - Gabor Maté (trauma-informed ayahuasca) - Hamilton Souther and established Western-trained curanderos in Iquitos --- ## Organizations ### Research Institutions - **Johns Hopkins Center for Psychedelic and Consciousness Research** — Premier academic node - **Imperial College Centre for Psychedelic Research** (London) — Carhart-Harris legacy; Nutt's base - **UC Berkeley Center for the Science of Psychedelics** — Third major academic hub - **Mount Sinai** — Yehuda's trauma-focused MDMA work ### Non-Profit Research & Advocacy - **MAPS** (Multidisciplinary Association for Psychedelic Studies) — Founded 1986; most important organization in the field; incubated Lykos Therapeutics for MDMA; hosts Psychedelic Science conference - **Beckley Foundation** (Amanda Feilding) — Foundational funder and research partner - **Usona Institute** — Non-profit psilocybin drug development; counterweight to for-profit model - **Heffter Research Institute** — Funds rigorous research; historically enabled Hopkins and NYU studies ### Commercial / Pharma - **COMPASS Pathways** — Psilocybin; publicly traded; pharma-oriented - **Gilgamesh Pharmaceuticals** — Bretisilocin (GM-2505); acquired by AbbVie for up to $1.2B in 2025 (first major pharma entry) - **Cybin (now Helus)** — Psychedelic drug development - **Delix Therapeutics** — Non-psychedelic neuroplasticity analogs (compounds without the subjective trip); key company to track in the non-hallucinogenic frontier - **Lykos Therapeutics** — MAPS-incubated MDMA drug development; FDA rejected application in 2024 over methodological concerns ### Policy & Reform - **Drug Policy Alliance** — Broader drug policy reform - **Students for Sensible Drug Policy** — Grassroots - **State-level programs:** Oregon Measure 109, Colorado Natural Medicine Health Act ### Conferences - **Psychedelic Science** (MAPS) — Flagship global conference (Denver 2025) - **ICPR** (Interdisciplinary Conference on Psychedelic Research) — Europe's most scientifically rigorous gathering - **ISRP** (International Society for Research on Psychedelics) — Academic society - **Breaking Convention** (UK) — Broad multidisciplinary ### Media & Analysis - **Psychedelic Alpha** (Josh Hardman) — Best independent analytical newsletter covering commercial and regulatory landscape - **Blossom Analysis** — Conference and research tracking --- ## Key Structural Tensions (2026) 1. **Pharma-medicalization vs. sacred-access:** The central conflict in the field. FDA-pathway (COMPASS, AbbVie/Gilgamesh, Cybin) versus decriminalization and state-regulated programs (Oregon, Colorado). 2. **Reductionist vs. transpersonal framing:** Clinical trials isolate pharmacological mechanism; indigenous and transpersonal traditions insist the subjective-spiritual dimension *is* the medicine. 3. **Non-psychedelic analogs:** Delix and others developing compounds that deliver neuroplasticity without the experiential journey — challenges the mystical-experience hypothesis. 4. **Indigenous sovereignty vs. Western extraction:** Ongoing tension around cultural appropriation, biopiracy, and commercialization of sacred traditions. 5. **FDA setbacks:** Lykos MDMA rejection (2024) raised the bar for trial design and shifted timelines. --- ## MDMA — Positioning Note MDMA is a purely synthetic empathogen — no indigenous ceremonial lineage, no plant-spirit relationship, no traditional container. Derived from safrole (sassafras oil); substituted phenethylamine; rediscovered by Shulgin in 1976; therapeutic legitimacy through the clinical-pharmacological pathway (Shulgin → MAPS → Phase 2/3 trials → trauma-processing model). **Harmonist positioning:** Outside the five cartographies as substance (modern synthetic, no lineage); inside them as territory (the Anāhata Heart-axis is what every cartography converges on naming as primary cultivational site — *kardia*, *qalb*, the Bhakti devotional Heart, *munay*, the Chinese Heart-Shen seat). Properly applied as both therapeutic instrument for targeted trauma work and as Heart-register transpersonal vehicle when intention is set right, within sustained practice and the discipline of rare-and-prepared use. Bears a Jing cost the Taoist framework reads precisely as serotonergic depletion and post-use Shen disturbance. Full canonical treatment: [[MDMA]]. --- ## Harmonism Integration Notes **Voices most coherent with Harmonic Realism:** - Grof — cartography of consciousness - Villoldo — embodied shamanic practice mapped to energy centers - Carhart-Harris — entropic brain as scientific correlate of mystical opening - Bache — sustained transpersonal exploration - Shipibo / Q'ero lineages — indigenous cosmology treating entheogenic encounter as diagnostic and energetic **Epistemological mapping:** The clinical-pharma axis operates at the rational-empirical layer — necessary but insufficient. The full entheogen encounter requires sensory → rational → experiential → mystical layers of the Harmonic Epistemology. The indigenous traditions naturally operate across all four layers simultaneously. **Wheel of Presence location:** Entheogens as a practice within the broader context of consciousness work — not isolated pharmacology but embedded within Breath, Peace (Ajna), and Love (Anahata) as the three essential practices. The entheogenic encounter is a catalyst, not a substitute, for the daily cultivation of presence.